This company has shut down. CARGO Therapeutics is no longer operating — its last tracked round was a Post-IPO Equity in 2024.
Explore the Startup GraveyardCARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
CARGO Therapeutics has raised $110.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2024.
CARGO Therapeutics's investors include Cormorant Asset Management, Janus Henderson Investors, Novo Holdings, Wellington Management, Samsara BioCapital.
CARGO Therapeutics is headquartered in San Mateo, United States.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
CARGO Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CARGO Therapeutics — Funding & Investors." VCBacked, May 28, 2024, https://www.vcbacked.co/company/cargo-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). CARGO Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cargo-therapeutics
{{cite web |title=CARGO Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cargo-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated